ArticleScientific reports2025
Gallic acid alleviates hippocampus and cerebellum injuries in a rat model of hepatic encephalopathy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver cirrhosis leads to portal hypertension and hepatic encephalopathy (HE). Bile duct ligation (BDL) is a valid model for developing HE in animal models. The present study investigated the protective effects of gallic acid (GA) against BDL-induced injuries in male rats. 64 male Wistar rats were randomly divided into eight equal groups: Sham, BDL, BDL+20 mg/kg GA, BDL+30 mg/kg GA, Sham+compound C (CC), BDL+CC, BDL+20 mg/kg GA+CC, and BDL+30 mg/kg GA+CC. The rats received GA by gavage and 6.2 µg of CC via bilateral intraventricular injection daily for four weeks. Serum ammonia, the expression of inflammatory cytokines and caspase-3 (Casp-3), and the number of degenerated neurons were significantly increased in BDL groups compared to the sham group. Antioxidant activity and adenosine monophosphate-activated protein kinase (AMPK) gene expression in the BDL groups significantly decreased compared to the sham group. GA significantly reduced serum ammonia, the expression of inflammatory cytokines, and Casp-3, as well as the number of degenerated neurons in the treated groups. GA significantly increased antioxidant activity and AMPK expression. In the groups that received CC, the improving effect of GA was reduced. GA could protect the hippocampus and cerebellum of male rats against the detrimental effects of BDL due to its antioxidant and anti-inflammatory properties and the activation of AMPK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.